@article{85c0fc5eb7ae415381918cf38208fe7f,
title = "COVID-19 vaccination and breakthrough infections in patients with cancer",
keywords = "COVID-19, SARS-CoV-2, cancer, neoplasm, vaccination, COVID-19 Vaccines, Humans, Vaccination, Neoplasms/complications",
author = "\{COVID-19 and Cancer Consortium\} and Schmidt, \{A. L.\} and C. Labaki and Hsu, \{C. Y.\} and Z. Bakouny and N. Balanchivadze and Berg, \{S. A.\} and S. Blau and A. Daher and \{El Zarif\}, T. and Friese, \{C. R.\} and Griffiths, \{E. A.\} and Hawley, \{J. E.\} and B. Hayes-Lattin and V. Karivedu and T. Latif and Mavromatis, \{B. H.\} and McKay, \{R. R.\} and G. Nagaraj and Nguyen, \{R. H.\} and Panagiotou, \{O. A.\} and Portuguese, \{A. J.\} and M. Puc and \{Santos Dutra\}, M. and Schroeder, \{B. A.\} and A. Thakkar and Wulff-Burchfield, \{E. M.\} and S. Mishra and D. Farmakiotis and Yu Shyr and Warner, \{J. L.\} and Choueiri, \{T. K.\} and N. Duma and P. Grivas and \{de Lima Lopes\}, G. and Painter, \{C. A.\} and S. Peters and Rini, \{B. I.\} and Shah, \{D. P.\} and Thompson, \{M. A.\}",
note = "Copyright {\textcopyright} 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.",
year = "2022",
month = mar,
doi = "10.1016/j.annonc.2021.12.006",
language = "English",
volume = "33",
pages = "340--346",
journal = "Annals of Oncology",
issn = "0923-7534",
number = "3",
}